| 项目 | RFCA组 | DT组 | ||
| 治疗前 | 治疗后 | 治疗前 | 治疗后 | |
| LVEF (%) | 60 (58, 62) | 60 (59, 62)* | 60 (58, 62) | 60 (58, 62) |
| LA内径(mm) | 44.1 ± 4.6 | 43.9 ± 3.8 | 44.7 ± 5.2 | 44.9 ± 5.1 |
| LVMI (g/m2) | 109 (101, 117) | 108 (101, 114)** | 108 (99, 118) | 110 (100, 121) |
| E/e' | 13 (11.3, 15.2) | 11.7 (10.1, 13.6)*** | 13.4 (11.1, 16.2) | 13.6 (11.5, 16.5) |
| NT-proBNP (pg/ml) | 668.9 (393.1, 1192.5) | 600 (408.3, 1149.8)** | 631.4 (321.2, 1239) | 741.4 (506.2, 1083.6) |